Lobbying client

NEXERA MEDICAL

Developer and manufacturer of medical products

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
23
Filed by
2
Reported in-house
—
Reported by firms
—

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2007 to 2012

Filings

23 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2012
US STRATEGIES — reported
4th Quarter - Report (No Activity)
4th Quarter 2011
US STRATEGIES — reported
3rd Quarter - Report
3rd Quarter 2011
US STRATEGIES — reported
2nd Quarter - Report
2nd Quarter 2011
US STRATEGIES — reported
1st Quarter - Report (No Activity)
1st Quarter 2011
US STRATEGIES — reported
4th Quarter - Report (No Activity)
4th Quarter 2010
US STRATEGIES — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2010
US STRATEGIES — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2010
US STRATEGIES — reported
1st Quarter - Report
1st Quarter 2010
US STRATEGIES — reported
4th Quarter - Report
4th Quarter 2009
US STRATEGIES — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
US STRATEGIES 14 —
ZELIFF ENTERPRISES 5 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 3293 111th 3

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.